应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
SAGE Sage Therapeutics
交易中 12-23 14:52:08 EST
5.48
-0.13
-2.32%
最高
5.77
最低
5.36
成交量
42.55万
今开
5.64
昨收
5.61
日振幅
7.22%
总市值
3.35亿
流通市值
2.65亿
总股本
6,117万
成交额
234.95万
换手率
0.88%
流通股本
4,835万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Sage Therapeutics, Inc.盘中异动 急速拉升5.00%
市场透视 · 12-21
Sage Therapeutics, Inc.盘中异动 急速拉升5.00%
Sage Therapeutics, Inc.盘中异动 下午盘股价大跌5.12%
市场透视 · 12-19
Sage Therapeutics, Inc.盘中异动 下午盘股价大跌5.12%
Sage Therapeutics, Inc.盘中异动 早盘股价大跌5.14%
市场透视 · 12-17
Sage Therapeutics, Inc.盘中异动 早盘股价大跌5.14%
Sage Therapeutics, Inc.盘中异动 股价大跌5.29%报5.37美元
市场透视 · 12-14
Sage Therapeutics, Inc.盘中异动 股价大跌5.29%报5.37美元
Sage Therapeutics, Inc.盘中异动 股价大涨5.21%
市场透视 · 12-12
Sage Therapeutics, Inc.盘中异动 股价大涨5.21%
【券商聚焦】摩根大通:欧洲软件与IT服务行业整体疲软 惟SAP和Sage估值有望稳中有升
金吾财讯 · 12-05
【券商聚焦】摩根大通:欧洲软件与IT服务行业整体疲软 惟SAP和Sage估值有望稳中有升
Sage Therapeutics, Inc.盘中异动 急速拉升5.12%
市场透视 · 12-03
Sage Therapeutics, Inc.盘中异动 急速拉升5.12%
Sage Therapeutics, Inc.盘中异动 早盘快速拉升5.30%
市场透视 · 11-27
Sage Therapeutics, Inc.盘中异动 早盘快速拉升5.30%
Sage Therapeutics, Inc.盘中异动 早盘股价大涨5.01%
市场透视 · 11-25
Sage Therapeutics, Inc.盘中异动 早盘股价大涨5.01%
Sage Therapeutics, Inc.盘中异动 急速拉升5.36%
市场透视 · 11-22
Sage Therapeutics, Inc.盘中异动 急速拉升5.36%
Sage Therapeutics, Inc.盘中异动 股价大涨5.70%
市场透视 · 11-21
Sage Therapeutics, Inc.盘中异动 股价大涨5.70%
美国研究综述-微策略、雪花、目标
Reuters · 11-21
美国研究综述-微策略、雪花、目标
BUZZ--美国股票走势-Williams-Sonoma, Inspire Medical, Lemonade Inc
路透中文 · 11-20
BUZZ--美国股票走势-Williams-Sonoma, Inspire Medical, Lemonade Inc
Sage Therapeutics, Inc.盘中异动 早盘股价大跌5.30%
市场透视 · 11-20
Sage Therapeutics, Inc.盘中异动 早盘股价大跌5.30%
BUZZ--美国股票走势-康卡斯特、Wix.com、Flex
Reuters · 11-20
BUZZ--美国股票走势-康卡斯特、Wix.com、Flex
BUZZ-Sage Therapeutics 停止开发罕见病药物后业绩下滑
路透中文 · 11-20
BUZZ-Sage Therapeutics 停止开发罕见病药物后业绩下滑
更新版 1-Sage Therapeutics因中期研究失败而放弃罕见病药物的开发
Reuters · 11-20
更新版 1-Sage Therapeutics因中期研究失败而放弃罕见病药物的开发
Sage Therapeutics的罕见病药物未能通过中期研究
路透中文 · 11-20
Sage Therapeutics的罕见病药物未能通过中期研究
Sage Therapeutics, Inc.盘中异动 股价大跌5.10%报4.84美元
市场透视 · 11-18
Sage Therapeutics, Inc.盘中异动 股价大跌5.10%报4.84美元
Sage Therapeutics, Inc.盘中异动 股价大跌5.06%报5.44美元
市场透视 · 11-15
Sage Therapeutics, Inc.盘中异动 股价大跌5.06%报5.44美元
加载更多
公司概况
公司名称:
Sage Therapeutics
所属市场:
NASDAQ
上市日期:
--
主营业务:
Sage Therapeutics, Inc.于2010年4月16号在特拉华州成立。该公司是一家生物制药公司,其使命是开拓解决方案,提供改变生命的大脑健康药物,让每个人都能茁壮成长。除了产后抑郁症商业产品外,该公司还针对临床开发和早期阶段的大脑疾病和障碍。作为一家公司,该公司专注于大脑健康,目前他们的目标是两个关键的中枢神经系统受体系统,GABA和NMDA。GABA受体家族被认为是中枢神经系统中主要的抑制性神经递质,通过激活GABAA受体介导下游的神经和身体功能。谷氨酸受体系统的NMDA型受体是中枢神经系统中的主要兴奋性受体系统。这些系统的功能障碍与广泛的中枢神经系统疾病有关。
发行价格:
--
{"stockData":{"symbol":"SAGE","market":"US","secType":"STK","nameCN":"Sage Therapeutics","latestPrice":5.48,"timestamp":1734983524011,"preClose":5.61,"halted":0,"volume":425531,"delay":0,"floatShares":48350863,"shares":61173263,"eps":-5.585057,"marketStatus":"交易中","marketStatusCode":2,"change":-0.13,"latestTime":"12-23 14:52:08 EST","open":5.64,"high":5.765,"low":5.36,"amount":2349473.246494,"amplitude":0.072193,"askPrice":5.48,"askSize":65,"bidPrice":5.46,"bidSize":870,"shortable":3,"etf":0,"ttmEps":-5.585057,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734987600000},"adr":0,"listingDate":1405656000000,"adjPreClose":5.61,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":5.8,"preClose":5.61,"latestTime":"08:18 EST","volume":1100,"amount":6380,"timestamp":1734959891247},"postHourTrading":{"tag":"盘后","latestPrice":5.54,"preClose":5.61,"latestTime":"19:50 EST","volume":190967,"amount":1071149.53,"timestamp":1734742221500},"volumeRatio":0.279398,"impliedVol":1.0835,"impliedVolPercentile":0.8287},"requestUrl":"/m/hq/s/SAGE","defaultTab":"news","newsList":[{"id":"2493425205","title":"Sage Therapeutics, Inc.盘中异动 急速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493425205","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493425205?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:37","pubTimestamp":1734712645,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时37分,Sage Therapeutics, Inc.股票出现波动,股价快速上涨5.00%。Sage Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.23%。其相关个股中,Abpro Holdings Inc C/Wts 12/11/2029 、Aptose Biosciences, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大,Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为2507.03%、379.54%、94.62%,振幅较大的相关个股有Abpro Holdings, Inc、Abpro Holdings Inc C/Wts 12/11/2029 、Aptose Biosciences, Inc.,振幅分别为173.15%、155.76%、105.11%。Sage Therapeutics, Inc.公司简介:Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122100372595ea9e91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122100372595ea9e91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAGE","BK4139","LENZ"],"gpt_icon":0},{"id":"2492155332","title":"Sage Therapeutics, Inc.盘中异动 下午盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492155332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492155332?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:12","pubTimestamp":1734552722,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时12分,Sage Therapeutics, Inc.股票出现波动,股价急速下挫5.12%。Sage Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为2.11%。其相关个股中,Polyrizon Ltd.、Tc Biopharm Plc C/Wts 10/02/2028 、Cardio Diagnostics Holdings Inc C/Wts To Pur Com涨幅较大,Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm Plc较为活跃,换手率分别为3196.64%、666.62%、346.99%,振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025,振幅分别为227.62%、138.10%、105.17%。Sage Therapeutics, Inc.公司简介:Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219041202984cb7e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219041202984cb7e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SAGE"],"gpt_icon":0},{"id":"2492650509","title":"Sage Therapeutics, Inc.盘中异动 早盘股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492650509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492650509?lang=zh_cn&edition=full","pubTime":"2024-12-17 22:46","pubTimestamp":1734446795,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日22时46分,Sage Therapeutics, Inc.股票出现异动,股价大幅下跌5.14%。Sage Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.42%。其相关个股中,Portage Biotech Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Tonix Pharmaceuticals Holding Corp.涨幅较大,Portage Biotech Inc.、Tonix Pharmaceuticals Holding Corp.、Polyrizon Ltd.较为活跃,换手率分别为1521.22%、127.85%、93.61%,振幅较大的相关个股有Tonix Pharmaceuticals Holding Corp.、Portage Biotech Inc.、Briacell Therapeutics Corp C/Wts 24/02/2025,振幅分别为86.79%、46.46%、23.99%。Sage Therapeutics, Inc.公司简介:Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121722463695ea3285&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121722463695ea3285&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAGE","LENZ","BK4139"],"gpt_icon":0},{"id":"2491308773","title":"Sage Therapeutics, Inc.盘中异动 股价大跌5.29%报5.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491308773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491308773?lang=zh_cn&edition=full","pubTime":"2024-12-14 01:09","pubTimestamp":1734109768,"startTime":"0","endTime":"0","summary":"北京时间2024年12月14日01时09分,Sage Therapeutics, Inc.股票出现异动,股价急速下跌5.29%。Sage Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.54%。其相关个股中,60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Celularity Inc C/Wts 16/07/2026 、Innate Pharma涨幅较大,Aptevo Therapeutics Inc.、Palisade Bio, Inc.、Candel Therapeutics, Inc.较为活跃,换手率分别为92.96%、85.90%、41.49%,振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029、Innate Pharma,振幅分别为65.55%、51.53%、48.39%。Sage Therapeutics, Inc.公司简介:Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214010928984bddfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214010928984bddfa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAGE","BK4139","LENZ"],"gpt_icon":0},{"id":"2490189674","title":"Sage Therapeutics, Inc.盘中异动 股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490189674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490189674?lang=zh_cn&edition=full","pubTime":"2024-12-12 02:28","pubTimestamp":1733941680,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日02时28分,Sage Therapeutics, Inc.股票出现异动,股价大幅拉升5.21%。Sage Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.16%。其相关个股中,Candel Therapeutics, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大,Silexion Therapeutics Corp、Candel Therapeutics, Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃,换手率分别为451.53%、265.54%、121.50%,振幅较大的相关个股有Candel Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Biora Therapeutics, Inc.,振幅分别为183.73%、127.38%、69.68%。Sage Therapeutics, Inc.公司简介:Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212022800984b5f16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212022800984b5f16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SAGE","BK4139"],"gpt_icon":0},{"id":"2489108167","title":"【券商聚焦】摩根大通:欧洲软件与IT服务行业整体疲软 惟SAP和Sage估值有望稳中有升","url":"https://stock-news.laohu8.com/highlight/detail?id=2489108167","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489108167?lang=zh_cn&edition=full","pubTime":"2024-12-05 11:05","pubTimestamp":1733367951,"startTime":"0","endTime":"0","summary":"金吾财讯 | 摩根大通对2025年欧洲软件与IT服务行业的前景进行了深入分析。报告指出,尽管2024年大多数欧洲软件与IT服务股票表现不佳,但SAP SE和Sage Therapeutics作为关键持有的股票,仍然展现出吸引力。报告提到2024年欧洲软件与服务行业整体下跌了17%,而SAP和Sage则分别上涨了+8%和+15%。摩根大通对欧洲该行业的整体看法是,尽管当前估值相对于历史水平更具吸引力,但对于大多数股票而言,市场尚未看到推动重估的催化剂。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/MmNiNjM2N2EzZjgxNTA4OTM0NTc2ODc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MmNiNjM2N2EzZjgxNTA4OTM0NTc2ODc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"282794","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BDRTCR15.USD","IE00BJTD4V19.USD","LU0048584097.USD","LU1668664300.SGD","LU0251132253.USD","LU1244550577.SGD","LU0256863811.USD","LU0976567544.SGD","LU0211327993.USD","LU1548497426.USD","BK4585","LU2552382215.SGD","LU0417517546.SGD","LU0106831901.USD","IE00BJTD4N35.SGD","SAP","IE00B1XK9C88.USD","LU0234572021.USD","LU1084165304.USD","SG9999002224.SGD","IE00BLSP4452.SGD","LU0267386448.USD","LU0149725797.USD","SAGE","IE00B1BXHZ80.USD","LU1894683264.USD","LU0971096721.USD","BK4023","LU0211331839.USD","BK4516","LU0215105999.USD","LU2552382058.USD","BK4566","LU1670628061.USD","LU1917777945.USD","LU0211328371.USD","LU2264538146.SGD","IE00BYXW3230.USD","LU1162221912.USD","LU1363072403.SGD","LU1914381329.SGD","LU2023250504.SGD","SG9999002232.USD","JPM","LU0683600562.USD","BK4550","IE00BBT3K403.USD","LU2106854487.HKD","BK4581","BK4504"],"gpt_icon":0},{"id":"2488460949","title":"Sage Therapeutics, Inc.盘中异动 急速拉升5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488460949","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488460949?lang=zh_cn&edition=full","pubTime":"2024-12-03 01:09","pubTimestamp":1733159348,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日01时09分,Sage Therapeutics, Inc.股票出现波动,股价急速上涨5.12%。Sage Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.01%。其相关个股中,Senti Biosciences, Inc.、Cingulate Inc C/Wts 10/12/2026 、Nutriband Inc C/Wts 涨幅较大,Senti Biosciences, Inc.、Quoin Pharmaceuticals Ltd、Revelation Biosciences, Inc.较为活跃,换手率分别为2204.09%、571.06%、258.25%,振幅较大的相关个股有Senti Biosciences, Inc.、Quoin Pharmaceuticals Ltd、Nutriband Inc C/Wts ,振幅分别为481.02%、131.67%、68.00%。Sage Therapeutics, Inc.公司简介:Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203010908971b33b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203010908971b33b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SAGE"],"gpt_icon":0},{"id":"2486839008","title":"Sage Therapeutics, Inc.盘中异动 早盘快速拉升5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486839008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486839008?lang=zh_cn&edition=full","pubTime":"2024-11-27 00:16","pubTimestamp":1732637785,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日00时16分,Sage Therapeutics, Inc.股票出现异动,股价急速上涨5.30%。Sage Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.42%。其相关个股中,Poseida Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Transcode Therapeutics, Inc.涨幅较大,Elevai Labs, Inc.、木薯科学、Poseida Therapeutics, Inc.较为活跃,换手率分别为39.88%、27.10%、22.56%,振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Tc Biopharm Plc C/Wts 10/02/2028 、Protagenic Therapeutics, Inc.,振幅分别为85.82%、57.50%、42.94%。Sage Therapeutics, Inc.公司简介:Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127001625a257764e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127001625a257764e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SAGE","BK4139"],"gpt_icon":0},{"id":"2486537039","title":"Sage Therapeutics, Inc.盘中异动 早盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486537039","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486537039?lang=zh_cn&edition=full","pubTime":"2024-11-25 23:33","pubTimestamp":1732548781,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日23时33分,Sage Therapeutics, Inc.股票出现异动,股价快速上涨5.01%。Sage Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为2.15%。其相关个股中,Alpha Tau Medical Ltd C/Wts 、Ocean Biomedical Inc C/Wts 14/02/2028 、Apollomics Inc C/Wts 01/04/2028 涨幅较大,木薯科学、Cognition Therapeutics, Inc.、Citius Pharmaceuticals, Inc.较为活跃,换手率分别为104.94%、100.28%、58.15%,振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、180 Life Sciences Corp C/Wts 07/11/2025、Exicure, Inc.,振幅分别为89.11%、65.85%、51.41%。Sage Therapeutics, Inc.公司简介:Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125233301971a8697&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125233301971a8697&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SAGE","LENZ"],"gpt_icon":0},{"id":"2485262504","title":"Sage Therapeutics, Inc.盘中异动 急速拉升5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485262504","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485262504?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:56","pubTimestamp":1732287368,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时56分,Sage Therapeutics, Inc.股票出现异动,股价急速上涨5.36%。Sage Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.45%。其相关个股中,Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Virpax Pharmaceuticals, Inc.、Replimune Group, Inc.涨幅较大,Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃,换手率分别为1269.37%、97.45%、75.27%,振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Exicure, Inc.、180 Life Sciences Corp C/Wts 07/11/2025,振幅分别为48.21%、42.08%、33.00%。Sage Therapeutics, Inc.公司简介:Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112222560898e442ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112222560898e442ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SAGE"],"gpt_icon":0},{"id":"2485497763","title":"Sage Therapeutics, Inc.盘中异动 股价大涨5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485497763","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485497763?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:31","pubTimestamp":1732199487,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时31分,Sage Therapeutics, Inc.股票出现异动,股价大幅拉升5.70%。Sage Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.22%。其相关个股中,Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Conduit Pharmaceuticals Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大,Conduit Pharmaceuticals Inc.、Biodexa Pharmaceuticals Plc、Tff Pharmaceuticals, Inc.较为活跃,换手率分别为211.05%、55.79%、41.53%,振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Conduit Pharmaceuticals Inc.、Assembly Biosciences, Inc.,振幅分别为14.55%、14.30%、12.18%。Sage Therapeutics, Inc.公司简介:Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121223128971a7df3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121223128971a7df3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SAGE","BK4139"],"gpt_icon":0},{"id":"2485550431","title":"美国研究综述-微策略、雪花、目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2485550431","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485550431?lang=zh_cn&edition=full","pubTime":"2024-11-21 14:34","pubTimestamp":1732170896,"startTime":"0","endTime":"0","summary":" 路透11月21日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价,其中包括 Microstrategy、Snowflake 和 Target。要闻 * Dycom Industries Inc :D.A. Davidson将目标价从210美元上调至220美元 * Microstrategy Inc :BTIG将目标价从290美元上调至570美元 * Snowflake Inc :Piper Sandler 将目标价从 165 美元上调至 185 美元 * Target Corp :杰富瑞将目标价从 195 美元下调至 165 美元 * Williams-Sonoma Inc :杰富瑞将目标价从 156 美元上调至 194 美元 以下是路透周四报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNOW","JACK","DY","LU0889565833.HKD","LU1951198990.SGD","LU2506952097.USD","BK4109","BK4023","PYXS","BK4209","BK4581","DNMR","BK4116","BK4600","LU2237443978.SGD","BK4533","LU2237443382.USD","TJX","BRBR","IE00B1BXHZ80.USD","BK4595","IE0004445239.USD","LU1244550221.USD","BK4111","TGT","TPIC","BK4585","LU1803068979.SGD","LU2506952170.USD","LU2237443549.SGD","SAGE","BERY","LU1989772840.SGD","IE00B19Z9Z06.USD","BK4183","NWSA","BK4592","LU0963586101.USD","BK4532","MSTR","BK4561","BK4596","BK4094","BK4535","IE00B19Z9P08.USD","FWONK","BK4108","FMNB","LU0211327993.USD"],"gpt_icon":1},{"id":"2484001146","title":"BUZZ--美国股票走势-Williams-Sonoma, Inspire Medical, Lemonade Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2484001146","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484001146?lang=zh_cn&edition=full","pubTime":"2024-11-20 23:57","pubTimestamp":1732118258,"startTime":"0","endTime":"0","summary":".N美国东部时间10:30,道琼斯工业平均指数.DJI下跌0.28%,报43,145.73点。标普500指数.SPX下跌0.78%,报5870.84点;纳斯达克综合指数.IXIC下跌1.16%,报18769.66点。标准普尔 500 指数.PG.INX涨幅前三名是: ** Keysight Technologies Inc KEYS.N,上涨 5.9. nL4N3MR0SH ** 金山云控股有限公司KC.O:BUZZ - 因第三季度亏损小于预期而上涨 nL8N3MR11B ** Silvercorp Metals Inc SVM.N:BUZZ - 在公布可转换债务交易后下跌 nL6N3MR0HA ** Tapestry Inc TPR.N: ** Capri Holdings Ltd CPRI.N:BUZZ - 巴克莱恢复对Tapestry和Capri的覆盖。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nL4T3MR19F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4516","BGC","FLEX","BK4539","IE00B1BXHZ80.USD","TGT","BK4507","SM","BK4555","BK4554","NEM","LU0950375773.USD","SAGE","LU0289961442.SGD","MBIN","SPAI","LMND","LU1430597077.USD","BK4195","LU1267930490.SGD","LU0075056555.USD","LU0980610538.SGD","DTM","TJX","WIX","CTVA","CMCSA","CMI","LU0310800965.SGD","OMCL","CPRI","TPR","QDEL","WSM","LU0788108826.HKD","DAL","INSP","MNPR","F","LU0094547139.USD","LU1280957306.USD","GDRX","VKTX","POWL"],"gpt_icon":1},{"id":"2484110660","title":"Sage Therapeutics, Inc.盘中异动 早盘股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484110660","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484110660?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:34","pubTimestamp":1732113260,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时34分,Sage Therapeutics, Inc.股票出现波动,股价快速下跌5.30%。Sage Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.33%。其相关个股中,Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp、Forte Biosciences, Inc.涨幅较大,Silexion Therapeutics Corp、Forte Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为501.30%、184.85%、106.42%,振幅较大的相关个股有Silexion Therapeutics Corp、Forte Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.,振幅分别为35.85%、30.55%、23.42%。Sage Therapeutics, Inc.公司简介:Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120223420971a7ad1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120223420971a7ad1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SAGE","BK4139"],"gpt_icon":0},{"id":"2484112793","title":"BUZZ--美国股票走势-康卡斯特、Wix.com、Flex","url":"https://stock-news.laohu8.com/highlight/detail?id=2484112793","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484112793?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:31","pubTimestamp":1732113071,"startTime":"0","endTime":"0","summary":"** Wix.com Ltd : BUZZ - 因上调财年营收和预订预期而跳涨 ** GoodRx Holdings Inc : BUZZ - Leerink 表示,该公司是价值被低估最严重的股票之一, 。** 达美航空 : BUZZ - 预测 2025 年收入将实现中等个位数增长,随后上涨。** 金山云控股有限公司 : BUZZ - 因第三季度亏损小于预期而上涨 ** Silvercorp Metals Inc : BUZZ - 在公布可转换债务交易后下跌","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4114","TGT","BK4112","CMCSA","SAGE","SM","RIOT","DAL","BK4554","BK4551","NEM","BK4100","LU0320765489.SGD","SPAI","BGC","LU1150488218.USD","MBIN","BK4195","BK4008","CTVA","BK4516","CMI","MARA","LU0057025933.USD","LU0124676726.USD","LU1280957306.USD","LU0630314457.HKD","FLEX","QDEL","GDRX","LU0823411888.USD","LU2098885051.SGD","BK4567","LU1223083913.SGD","LU0788108826.HKD","LU0648001328.SGD","BK4596","LU1861559042.SGD","BK4198","VKTX","WIX","LU0289961442.SGD","LU0154245756.USD","LU0456854461.SGD","COIN","MNPR","LU0612318385.USD"],"gpt_icon":1},{"id":"2484011698","title":"BUZZ-Sage Therapeutics 停止开发罕见病药物后业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2484011698","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484011698?lang=zh_cn&edition=full","pubTime":"2024-11-20 21:27","pubTimestamp":1732109220,"startTime":"0","endTime":"0","summary":"11月20日 - ** 药物开发商 Sage Therapeutics 的 SAGE.O 股价盘前下跌 4.3% 至 4.70 美元** 该公司表示,由于在一项中期试验中没有达到主要目标 ,它将停止进一步开发其试验性药物dalzanemdor。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nL4T3MR0ZR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SAGE"],"gpt_icon":0},{"id":"2484940561","title":"更新版 1-Sage Therapeutics因中期研究失败而放弃罕见病药物的开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2484940561","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484940561?lang=zh_cn&edition=full","pubTime":"2024-11-20 19:54","pubTimestamp":1732103650,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) (在第2段中增加了股票,并在全文中提供了详细信息) 路透11月20日 - 药物开发商Sage Therapeutics 周三表示 ,其治疗亨廷顿氏病患者认知障碍的实验性药物在一项中期研究失败后将停止开发。与安慰剂相比,这种名为dalzanemdor的药物在84天后没有明显改善患者的认知功能,未能达到研究的主要目标。萨奇说,该药物在研究的次要目标中也没有达到 \"统计学意义\"。 亨廷顿氏病是一种遗传性疾病,会导致大脑部分神经细胞逐渐坏死。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4139","SAGE"],"gpt_icon":0},{"id":"2484917381","title":"Sage Therapeutics的罕见病药物未能通过中期研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2484917381","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484917381?lang=zh_cn&edition=full","pubTime":"2024-11-20 19:36","pubTimestamp":1732102572,"startTime":"0","endTime":"0","summary":"Sage Therapeutics的罕见病药物未能通过中期研究路透11月20日 - Sage Therapeutics SAGE.O周三表示,在一项针对罕见遗传性神经疾病亨廷顿氏病患者的中期研究中,其实验性药物未能达到主要目标。 (为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nL4T3MR0RM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SAGE","BK4139"],"gpt_icon":0},{"id":"2484671616","title":"Sage Therapeutics, Inc.盘中异动 股价大跌5.10%报4.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484671616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484671616?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:33","pubTimestamp":1731940393,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时33分,Sage Therapeutics, Inc.股票出现波动,股价大幅下挫5.10%。Sage Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.15%。其相关个股中,Hcw Biologics Inc.、冠科美博、Fate Therapeutics, Inc.涨幅较大,Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃,换手率分别为517.58%、212.65%、190.21%,振幅较大的相关个股有Hcw Biologics Inc.、Fate Therapeutics, Inc.、冠科美博,振幅分别为57.71%、35.15%、34.31%。Sage Therapeutics, Inc.公司简介:Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822331398e433d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822331398e433d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SAGE","LENZ"],"gpt_icon":0},{"id":"2483820593","title":"Sage Therapeutics, Inc.盘中异动 股价大跌5.06%报5.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483820593","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483820593?lang=zh_cn&edition=full","pubTime":"2024-11-15 01:34","pubTimestamp":1731605670,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日01时34分,Sage Therapeutics, Inc.股票出现波动,股价快速下跌5.06%。Sage Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.83%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Molecular Templates, Inc.、奥麦罗制药涨幅较大,Molecular Templates, Inc.、Elevai Labs, Inc.、Pulmatrix, Inc.较为活跃,换手率分别为3671.25%、3218.98%、365.57%,振幅较大的相关个股有Molecular Templates, Inc.、Pulmatrix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为249.67%、112.92%、106.82%。Sage Therapeutics, Inc.公司简介:Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115013430abc1c36d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115013430abc1c36d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SAGE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sagerx.com","stockEarnings":[{"period":"1week","weight":0.0418},{"period":"1month","weight":0.1426},{"period":"3month","weight":-0.252},{"period":"6month","weight":-0.496},{"period":"1year","weight":-0.7387},{"period":"ytd","weight":-0.7411}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Sage Therapeutics, Inc.于2010年4月16号在特拉华州成立。该公司是一家生物制药公司,其使命是开拓解决方案,提供改变生命的大脑健康药物,让每个人都能茁壮成长。除了产后抑郁症商业产品外,该公司还针对临床开发和早期阶段的大脑疾病和障碍。作为一家公司,该公司专注于大脑健康,目前他们的目标是两个关键的中枢神经系统受体系统,GABA和NMDA。GABA受体家族被认为是中枢神经系统中主要的抑制性神经递质,通过激活GABAA受体介导下游的神经和身体功能。谷氨酸受体系统的NMDA型受体是中枢神经系统中的主要兴奋性受体系统。这些系统的功能障碍与广泛的中枢神经系统疾病有关。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.038293},{"month":2,"riseRate":0.4,"avgChangeRate":-0.021443},{"month":3,"riseRate":0.4,"avgChangeRate":-0.042022},{"month":4,"riseRate":0.6,"avgChangeRate":0.045083},{"month":5,"riseRate":0.4,"avgChangeRate":-0.009805},{"month":6,"riseRate":0.5,"avgChangeRate":0.012627},{"month":7,"riseRate":0.5,"avgChangeRate":-0.009867},{"month":8,"riseRate":0.636364,"avgChangeRate":-0.042534},{"month":9,"riseRate":0.454545,"avgChangeRate":-0.036732},{"month":10,"riseRate":0.363636,"avgChangeRate":0.008484},{"month":11,"riseRate":0.636364,"avgChangeRate":0.056493},{"month":12,"riseRate":0.636364,"avgChangeRate":0.051226}],"exchange":"NASDAQ","name":"Sage Therapeutics","nameEN":"Sage Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sage Therapeutics(SAGE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Sage Therapeutics(SAGE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Sage Therapeutics,SAGE,Sage Therapeutics股票,Sage Therapeutics股票老虎,Sage Therapeutics股票老虎国际,Sage Therapeutics行情,Sage Therapeutics股票行情,Sage Therapeutics股价,Sage Therapeutics股市,Sage Therapeutics股票价格,Sage Therapeutics股票交易,Sage Therapeutics股票购买,Sage Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sage Therapeutics(SAGE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Sage Therapeutics(SAGE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}